Related references
Note: Only part of the references are listed.Degradome of soluble ADAM10 and ADAM17 metalloproteases
Franka Scharfenberg et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Tissue Inhibitor of Metalloproteinase 3 Deficiency Disrupts the Hepatocyte E-Cadherin/β-Catenin Complex and Induces Cell Death in Liver Ischemia/Reperfusion Injury
Takehiro Fujii et al.
LIVER TRANSPLANTATION (2020)
TIMP-3 facilitates binding of target metalloproteinases to the endocytic receptor LRP-1 and promotes scavenging of MMP-1
Anna P. Carreca et al.
SCIENTIFIC REPORTS (2020)
NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease
Tobias Brummer et al.
EMBO MOLECULAR MEDICINE (2019)
The molecular, cellular and pathophysiological roles of iRhom pseudoproteases
Iqbal Dulloo et al.
OPEN BIOLOGY (2019)
Identification of ADAM12 as a Novel Basigin Sheddase
Reidar Albrechtsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Functions of A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system
Hung-En Hsia et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments
Stefan F. Lichtenthaler et al.
EMBO JOURNAL (2018)
Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor
Simone D. Scilabra et al.
SCIENTIFIC REPORTS (2018)
Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
Alexandra L. Matthews et al.
PLATELETS (2017)
An activated form of ADAM10 is tumor selective and regulates cancer stem-like cells and tumor growth
Lakmali Atapattu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Systematic substrate identification indicates a central role for the metalloprotease ADAM10 in axon targeting and synapse function
Peer-Hendrik Kuhn et al.
ELIFE (2016)
Proteomic Substrate Identification for Membrane Proteases in the Brain
Stephan A. Mueller et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Membrane-type matrix metalloproteinases: Their functions and regulations
Yoshifumi Itoh
MATRIX BIOLOGY (2015)
Inflammation-induced desmoglein-2 ectodomain shedding compromises the mucosal barrier
Ryuta Kamekura et al.
MOLECULAR BIOLOGY OF THE CELL (2015)
Protein-tyrosine Pseudokinase 7 (PTK7) Directs Cancer Cell Motility and Metastasis
Vladislav S. Golubkov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Direct Detection of Biotinylated Proteins by Mass Spectrometry
Lucio Matias Schiapparelli et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ
Juergen Cox et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding
Thorsten Maretzky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Overexpression of Tissue Inhibitor of Metalloproteinase 3 in Macrophages Reduces Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice
Viviana Casagrande et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Tumor suppressor cell adhesion molecule 1 (CADM1) is cleaved by a disintegrin and metalloprotease 10 (ADAM10) and subsequently cleaved by γ-secretase complex
Yusuke Nagara et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Ectodomain shedding and ADAMs in development
Silvio Weber et al.
DEVELOPMENT (2012)
TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
Rossella Menghini et al.
DIABETES (2012)
Matrix Metalloproteinase-2 Cleavage of the β1 Integrin Ectodomain Facilitates Colon Cancer Cell Motility
Jakub Kryczka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Nuclear Targeting of IGF-1 Receptor in Orbital Fibroblasts from Graves' Disease: Apparent Role of ADAM17
Neil Hoa et al.
PLOS ONE (2012)
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells
M. C. Anania et al.
ONCOGENE (2011)
A Novel Extracellular Hsp90 Mediated Co-Receptor Function for LRP1 Regulates EphA2 Dependent Glioblastoma Cell Invasion
Udhayakumar Gopal et al.
PLOS ONE (2011)
ADAM15 Exerts an Antiapoptotic Effect on Osteoarthritic Chondrocytes via Up-Regulation of the X-Linked Inhibitor of Apoptosis
Beate Boehm et al.
ARTHRITIS AND RHEUMATISM (2010)
The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity
Keith Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Human ROBO1 is cleaved by metalloproteinases and γ-secretase and migrates to the nucleus in cancer cells
Motoaki Seki et al.
FEBS LETTERS (2010)
Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays
Thorsten Maretzky et al.
BIOCHEMICAL JOURNAL (2009)
TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1
Marina Cardellini et al.
DIABETES (2009)
LRP1 shedding in human brain: roles of ADAM10 and ADAM17
Qiang Liu et al.
MOLECULAR NEURODEGENERATION (2009)
The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3
Linda Troeberg et al.
MATRIX BIOLOGY (2009)
Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum
Guangbo Zhang et al.
IMMUNOLOGY (2008)
Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation
Erin M. Conn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
LDL receptor-related protein 1: Unique tissue-specific functions revealed by selective gene knockout studies
Anna P. Lillis et al.
PHYSIOLOGICAL REVIEWS (2008)
Increased collagen and aggrecan degradation with age in the joints of Timp3-/- mice
Solmaz Sahebjam et al.
ARTHRITIS AND RHEUMATISM (2007)
Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells
Phillip C. C. Liu et al.
CANCER BIOLOGY & THERAPY (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
In vivo protein biotinylation and sample preparation for the proteomic identification of organ- and disease-specific antigens accessible from the vasculature
Christoph Roesli et al.
NATURE PROTOCOLS (2006)
In-gel digestion for mass spectrometric characterization of proteins and proteomes
Andrej Shevchenko et al.
NATURE PROTOCOLS (2006)
Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-α
M Federici et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis
M Mahmoodi et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro
RA Asher et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2005)
Homeostatic effects of the metalloproteinase disintegrin ADAM15 in degenerative cartilage remodeling
BB Böhm et al.
ARTHRITIS AND RHEUMATISM (2005)
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration
FF Mohammed et al.
NATURE GENETICS (2004)
TIMP-3 deficiency leads to dilated cardiomyopathy
PWM Fedak et al.
CIRCULATION (2004)
Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
ML Fitzgerald et al.
JOURNAL OF CELL BIOLOGY (2000)